BioSpace GenePool
   Monday, November 24, 2008 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
TOP SPONSOR

In its 13th year, Drug Delivery Partnerships is the global meeting place for the Drug Delivery Industry. Participants from the Pharma, Biotech, Specialty Pharma and Generic industries come together to seek the latest strategies, industry updates, and networking opportunities to help position their company for a successful partnership/collaboration.

For more information, please visit: http://www.drugdeliverypartnerships.com
Top Stories 
•  King Pharmaceuticals®, Inc.To Acquire Alpharma Inc. (ALO) for Approximately $1.6 Billion More...
•  Johnson & Johnson (JNJ) (JOBS) Acquire Omrix Biopharmaceuticals, Inc. (OMRI) for $438 Million More...
•  FDA Approves Johnson & Johnson (JNJ)'s (JOBS) Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain More...
•  Accentia Biopharmaceuticals (ABPI) Reorganization Claims More Jobs More...
•  Exelixis, Inc. (EXEL) to Co-develop Cancer Therapy with Bristol-Myers Squibb Company (BMY) (JOBS); Exelixis to Receive $20 Million More...
•  Amulet Pharmaceuticals Inc. Up for Sale, a Year After Moving to Rockville More...
•  Genentech, Inc. (DNA)'s (JOBS) Avastin Meets Breast Cancer Study Goal More...
•  FDA Extends Review of Somaxon Pharmaceuticals, Inc. New Drug Application for Silenor(R) (Doxepin) by up to Three Months More...

More Top News
Don't Miss This
Invitrogen PD-Direct(R) Bioprocess Services

PD-Direct(R) is our integrated service offering that provides streamlined solutions for process development. You can reduce process development inefficiencies and improve time and cost performance using the latest technologies and resources from Invitrogen.

The PD-Direct(R) Bioprocess Services team provides technical expertise and in-depth regulatory knowledge, solving manufacturing process challenges at every phase of development.

Please click here for more information.
Featured Stories
•  Government Pays Millions for Unapproved Drugs More...
•  Biotech Industry Facing Financing Crisis As Capital Dries Up More...
•  India's Biotech Sector Set To Thrive Despite Downturn More...
•  'Sticky Cell' Clues To Epilepsy; University of Verona Scientists Shed Light On Causes Of Epilepsy More...
•  New Technique Eliminates Toxic Drugs In Islet Transplant In Diabetic Mice, Northwestern University Feinberg School of Medicine Study More...
•  Inside-out Cells Offer Target for Antiviral Drugs, University of Texas Southwestern Medical Center Study More...
•  Hairspray Is Linked To Common Genital Birth Defect, Says Imperial College London, University College Cork, And the Centre for Research in Environmental Epidemiology Study More...
•  Brain Abnormalities That May Play Key Role In ADHD, Kennedy Krieger Institute And Johns Hopkins University Study More...

Biotech Bay Forum
 
More Featured News
Event of the day
The SafeBridge Potent Compound Safety "Boot Camp"(R) is a comprehensive course in pharmaceutical potent compound safety with a focus on training EH&S and related professionals in critical technical concepts and proactive safety programs in the pharmaceutical, chemical and biotechnology industries. This intensive course presents technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication and is a blend of lectures, case studies, scenarios, individual and group exercises and video training.

COURSE SEATING IS LIMITED AND USUALLY SELLS OUT!

Next US Offering: Feb 4-5, 2009;
Location: San Francisco, California. USA
Registration: First registration $1950 additional company representative $1750.
Contact: Susan Custer, Email: susan.custer@safebridge.com or Call: 650-961-4820 x 231

Web site: www.safebridge.com
Latest Market Insight
The Future of RNAi Therapeutics: Drug Pipelines and Prospects

• Analyze emerging RNAi agents and delivery technologies and examine new molecular targets and pipeline antisense drugs.
• Evaluate 97 RNAi compounds in development for infectious and inflammatory diseases, cancer and other major disease categories.
• Assess 37 competitors and potential collaborators developing RNAi technologies and examine the latest RNAi-related patenting trends.
• Identify potential growth segments and develop future strategies with this report's forecasts for the global RNAi therapy market to 2012.

Click Here for More Information
Top Jobs
Genetown (Boston, Massachusetts) Hot Job of the Day:

DiscoveRx Corporation
Field Application Scientist
The successful candidate for Field Application Scientist will support the sales organization by providing pre- and post-sales technical support to customers, training new customers in the proper use of DiscoveRx products, and developing and maintaining customer relationships within Key Accounts in New England and the Mid-West.

Pharm Country (Lehigh Valley, Pennsylvania) Hot Job of the Day:

The Cypress Group
Sr. Regulatory Affairs – Med/Pharma
You will be responsible for working on cross functional project teams to ensure compliance with all regulatory requirements both domestically and internationally. You will be a liaison with all regulatory organizations such as the FDA or international equivalent.

Biotech Beach (Irvine, California) Hot Job of the Day:

B Braun Medical
Mechanical and Automation Engineers
Research, develop and prepare specifications for new products, processes, equipment, and technology. Manage projects by developing a project schedule and team, tracking costs, preparing status reports conducting team meetings, and communicating issues and progress to management.

Southern Pharm (Memphis, Tennessee) Hot Job of the Day:

St. Jude Children's Research Hospital
Senior Research Technologist
The Senior Research Technologist in the Genetics and Tumor Cell Biology Department operates as an advanced-level Research Technologist by assisting the principal investigator with the data collection and analysis for research projects.

Biotech Bay (Palo Alto, California) Hot Job of the Day:

Stanford University
Proteomics Core Facility Director
The Proteomics Facility Core Director for the Canary Center at Stanford has primary responsibility for serving as a resource to help early detection faculty and researchers in the Center, on the Stanford campus, and at other collaborating institutions interface with the core resources.

Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center!

BioSpace Career Fairs
January 28, 2009 Biotech Bay Career Fair

BioSpace and DeviceSpace are joining forces to present the Biotech Bay Career Fair on Wednesday, January 28, 2009 at the South San Francisco Conference Center in South San Francisco, CA.

The Biotech Bay Career Fair will provide unlimited opportunities to individuals in the pharmaceutical, biotech, medical device and diagnostics fields. Qualified job seekers and top companies in the industry can come together in one convenient location to interview for hundreds of open positions.

Do not miss the chance to interview with the biopharmaceutical industry's most prestigious companies!

Click Here TO SUBMIT YOUR RESUME FOR THE BIOTECH BAY CAREER FAIR NOW!

Qualified candidates will receive their invitations and confirmation numbers via email 24 to 48 hours after their resumes have been submitted. Pre-screened and accepted candidates must bring a copy of their invitation with confirmation number to the event.

We look forward to seeing you at the Biotech Bay Career Fair!

Biotech Bay Career Fair, January 28, 2009
Pharm Country Career Fair, February 2, 2009
CALAsia La Jolla Career Fair, February 23, 2009

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services

Company of the day



Endo Pharmaceuticals Inc.
100 Painters Crossing
Chadds Ford, Pennsylvania 19317 U.S.A.
Phone: 610-558-9800
View Jobs

Endo became Endo Pharmaceuticals Inc. (NASDAQ: ENDP) as a result of a management buyout from DuPont Merck in 1997. We are a specialty pharmaceutical company engaged in the research, development, sale and marketing of prescription pharmaceuticals used primarily to treat and manage pain.
Free Resources
FREE Subscription to Nature Biotechnology

Nature Biotechnology devotes pages specifically to in-depth analysis of issues concerning biotechnology intellectual property case law and policy, together with breaking news on patents. Also included in each issue are key emerging areas such as computational biology and materials science.
Contact Us

Send questions and comments to the BioSpace NewsBeat Team East Coast Office:
    BioSpace, Inc.
    Ramshorn Executive Centre
    2399 Highway 34, Building A-5
    Manasquan, New Jersey 08736-1528 U.S.A.
    Phone: 732-528-3688
    Fax: 732-528-3668
West Coast Office:
    BioSpace, Inc.
    90 New Montgomery Street, Suite 414
    San Francisco, California 94105 U.S.A.
    Phone: 877-277-7585
    Fax: 415-576-9217
Editor & Publisher:
    Rosemary Do
Editorial & Production Staff:
    Annalyn Aquino
    Suvarna Bhatt
    Lana Ho
    Matt Thwin
BioSpace.com - Life * Science * Community

WEDDLE's 2008 User's Choice Award for Best Job Boards
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2008 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply join the BioSpace GenePool here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here or by clicking on the "unsubscribe" link at the bottom of this newsletter.